Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis

Abstract

BackgroundIt is unknown whether nitrofurantoin 50 mg normal-release every 6 h (NF50) and nitrofurantoin 100 mg extended-release every 12 h (NF100) are equally effective for treating cystitis in primary care. In the Netherlands, GP prescription of either option largely depends on pharmacy procurement, rather than on patient-related factors.MethodsGP data between January 2013 and July 2018 were retrospectively collected. Inclusion criteria were the use of nitrofurantoin for uncomplicated cystitis, complicated cystitis or cystitis in pregnancy. Criteria for early and late failure were a second antibiotic prescription for cystitis or pyelonephritis within 14 and 28 days post-prescription, respectively. Crude and confounder-adjusted (CA) risk differences (RDs) were estimated using linear regression. Instrumental variable analysis and CA instrumental variable analysis used GP practice proportion of NF50 versus NF100 use as the instrumental variable.ResultsFor uncomplicated cystitis (n=46855), treatment with NF50 and NF100 resulted in late failure in 9.7% and 9.6%, respectively. The CA RD, instrumental variable RD and CA instrumental variable RD were 0.2% (95% CI=−0.5 to 0.8), −0.7% (95% CI=−1.7 to 0.3) and 0.0% (95% CI=−0.9 to 1.0), respectively. In complicated cystitis (n=10767), late failure occurred in 10.9% and 11.1% after using NF50 and NF100, respectively [CA RD=0.5% (95% CI=−1.2 to 1.8), instrumental variable RD=−0.8% (95% CI=−3.4 to 1.8) and CA instrumental variable RD=−0.3% (95% CI=−3.0 to 2.4)]. For cystitis in pregnancy (n=1087), NF50 and NF100 resulted in late failure in 13.4% and 7.8%, respectively [CA RD=−5.4% (95% CI=−10.0 to −1.4), instrumental variable RD=−8.9% (95% CI=−16.0 to −1.8) and CA instrumental variable RD=−8.9% (95% CI=−16.0 to −1.7)]. No differences were observed in early failure.ConclusionsIn patients with cystitis in pregnancy, NF100 was associated with a lower incidence of late clinical failure compared with NF50. We found no differences in clinical failure between NF50 and NF100 for uncomplicated and complicated cystitis.

Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: the impact of dosing regimen, age, and renal function on drug exposure

“…In our study, the PK of nitrofurantoin was independent of the dose and formulation of the dose regimens. These results suggest that the urinary PK of nitrofurantoin is not dependent on dose or formulation alone as was described by ten Doesschate [ 29 ]. Possible other contributing factors of PK could be lifestyle, fluid intake, nutrition, and voiding pattern.…”

Antibiotic treatment failure of uncomplicated urinary tract infections in primary care

“…Although antibiotic treatment failure in uncomplicated UTIs may lead to complications such as pyelonephritis and sepsis, the impact of prescribing empirical antibiotics in relation to local antibiotic susceptibility patterns have not been well studied. While primary care studies worldwide detected a 10–18% antibiotic treatment failure rate for uncomplicated UTIs [ 7 – 10 ], differing outcome definitions made comparisons challenging [ 11 ]. Locally, the percentage of patients returning for treatment failure after initial antibiotic treatment of UTIs remained unknown.…”

Gasdermin D: A potential mediator and prognostic marker of bladder cancer

“…Chronic inflammation can induce DNA damage via creation of reactive oxygen and nitrogen species ( Ten Doesschate et al, 2019 ). These reactive species such as superoxide anion, hydrogen peroxide, and nitric oxide are produced by cells involved in inflammation like neutrophils, monocytes, and macrophages ( Ambite et al, 2016 ).…”